North Korea yet to approve new TB-malaria treatment grant, Global Fund says



News North Korea yet to approve new TB-malaria treatment grant, Global Fund says "Critically important" that medication order be placed soon, NGO spokesperson tells NK News Oliver Hotham October 18, 2019 SHARE COPY LINK FACEBOOK X LINKEDIN MASTODON NK News North Korean authorities are yet to approve a $41.7 million grant from international financing organization the Global Fund, a spokesperson confirmed to NK News on Thursday, in a delay that comes amid increased concerns about shortages of urgently-needed drugs in the country. Global Fund, which controversially ended its North Korea operations in 2018, announced last month that its board had approved a major new grant for in-country work and that the project was awaiting government approval. North Korean authorities are yet to approve a $41.7 million grant from international financing organization the Global Fund, a spokesperson confirmed to NK News on Thursday, in a delay that comes amid increased concerns about shortages of urgently-needed drugs in the country. Global Fund, which controversially ended its North Korea operations in 2018, announced last month that its board had approved a major new grant for in-country work and that the project was awaiting government approval. Become a member for less than $5.75 per week. Unlimited access to all of NK News: reporting, investigations, analysis The NK News Daily Update, an email newsletter to keep you in the loop Searchable archive of all content, photo galleries, special columns Contact NK News reporters with tips or requests for reporting Get unlimited access to all NK News content, including original reporting, investigations, and analyses by our team of DPRK experts. Subscribe now All major cards accepted. No commitments – you can cancel any time. © Korea Risk Group. All rights reserved. No part of this content may be reproduced, distributed, or used for commercial purposes without prior written permission from Korea Risk Group. Get the Daily Update Start your day with the North Korea stories that matter most – as selected by And how should we address you in correspondence? One more step! Please check your inbox, for an email we just sent you, and click on the confirmation message in it to get subscribed to our Daily News Update. Trending

News

North Korea yet to approve new TB-malaria treatment grant, Global Fund says

"Critically important" that medication order be placed soon, NGO spokesperson tells NK News

Oliver Hotham October 18, 2019

North Korea yet to approve new TB-malaria treatment grant, Global Fund says

NK News

North Korean authorities are yet to approve a $41.7 million grant from international financing organization the Global Fund, a spokesperson confirmed to NK News on Thursday, in a delay that comes amid increased concerns about shortages of urgently-needed drugs in the country.

Global Fund, which controversially ended its North Korea operations in 2018, announced last month that its board had approved a major new grant for in-country work and that the project was awaiting government approval.

Become a member for less
than $5.75 per week.

Unlimited access to all of NK News: reporting, investigations, analysis
The NK News Daily Update, an email newsletter to keep you in the loop
Searchable archive of all content, photo galleries, special columns
Contact NK News reporters with tips or requests for reporting

Get unlimited access to all NK News content, including original reporting, investigations, and analyses by our team of DPRK experts.

Subscribe now

All major cards accepted. No commitments – you can cancel any time.

North Korea yet to approve new TB-malaria treatment grant, Global Fund says

Become a member for less than $5.75 per week.

Start your day with the North Korea stories that matter most –

as selected by <img width="226" height="50" class="logo" src="https://www.nknews.org/wp-content/themes/nknews/images/header-logo.png" alt="NK News Logo">

One more step!

Trending

Recent Stories

About the Author

Oliver Hotham

Become a member for less
than $5.75 per week.

Start your day with
the North Korea stories that matter most –

as selected by